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SUMMARY – Urinary tract infections (UTIs) are among the most common bacterial infecti-
ons in adult population. They are prevalent in all age groups both in women and men. Also, UTIs 
are the most frequent indication for empirical antibiotic treatment in emergency department. The 
aim of this study was to determine the antibiotic resistance rates in the treatment of uncomplicated 
UTIs. Adult patients admitted to emergency department with uncomplicated UTIs were included 
in this cross-sectional study. Mid-stream urine samples were obtained under sterile conditions and 
cultured quantitatively. After 24 hours, the samples showing 105 colony forming unit per millili-
ter (CFU/mL) were tested for antibiotic susceptibility. Resistance to fosfomycin-trometamol (FT), 
amoxicillin-clavulanic acid (AC), ciprofloxacin (CIP), trimethoprim-sulfamethoxazole (TMP-
SMX) and cefpodoxime (CEF) was tested by Kirby-Bauer disc diffusion system. Escherichia (E.) 
coli accounted for the vast majority (93.4%) of the organisms isolated in the study. Among the E. coli 
positive patients, resistance to TMP-SMX was the most common antibiotic resistance. The E. coli 
species detected in our study group were least resistant to FT (2.4%). The resistance rates, especially 
to CEF, AC and CIP, were significantly higher in patients over 50 years of age. In conclusion, in the 
treatment of uncomplicated UTIs, TMP-SMX should be excluded from empirical treatment, while 
fosfomycin could be a viable option in all age groups.
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Introduction
Urinary tract infections (UTIs) are among the 
most common bacterial infections in adult popula-
tion. In the United States, there are nearly 10 million 
outpatient visits for UTIs annually. Almost one-fifth 
of these visits are to hospital emergency departments. 
UTIs are also the most common primary diagnosis in 
women presenting to emergency departments1. Acute 
cystitis and pyelonephritis are the most frequent in-
dications for empirical antibiotic treatment without 
urine culture, especially in emergency department2. 
However, the success of infection treatment is di-
rectly related to rational prescription of antibiotics. 
Due to the resistance problem, inappropriate use of 
antibiotics leads universally to high medical expenses. 
In 2012, the study by Mollahaliloglu et al. demon-
strated that the most common diagnosis in prescrip-
tions containing antibiotics was “urinary tract infec-
tion”. When calculating the cost of prescriptions, they 
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observed that antibiotics accounted for 50.7% of the 
total cost3.
The responsible bacteria in most UTIs are the En-
terobacteriaceae species. Escherichia (E.) coli is the most 
frequently isolated bacterium with a prevalence rate 
of 75%-95%. Proteus mirabilis, Klebsiella pneumoniae 
and Staphylococcus saprophyticus are other frequently 
observed species in young and healthy women (5%-
15%)2,4. In adult male patients, E. coli is also the most 
frequently observed causative organism. Proteus, Kleb-
siella, Serratia, Pseudomonas and other Enterococcus 
species are also isolated in urine cultures, especially in 
older male patients5.
Urinary tract infections are usually described un-
der the headings of complicated and uncomplicated 
infections because of the need for different treatment 
strategies. Uncomplicated UTIs are infections of the 
urinary system in patients without any neurological, 
functional or anatomical abnormalities and are usu-
ally observed in young healthy and non-pregnant 
women. The risk factors for complicated UTIs include 
male sex, advanced age, hospitalization, pregnancy, 
urinary catheter, residual urine in the bladder, func-
tional or anatomical abnormalities of urinary tract, 
immunosuppression, diabetes mellitus, symptoms 
lasting for more than seven days, and inappropriate 
antibiotic treatment6. UTIs are very rarely observed 
in men aged 15-50. However, if pyelonephritis is di-
agnosed in this age group, it almost always presents 
a risk factor. Another important thing is that there 
is usually recurrence of the infection and undetected 
resistance to antibiotics in most complicated UTIs7,8. 
Empirical prescription of inappropriate antibiotics is 
probably the main reason for the increased rates of an-
timicrobial resistance.            
The Infectious Disease Society of America and 
the European Society for Microbiology and Infec-
tious Diseases Committee have published the latest 
recommendations for the treatment of uncomplicated 
UTIs. It is emphasized in the guideline that the rec-
ommendations are limited, and must be updated ac-
cording to the regional antimicrobial resistance rates 
and patterns. According to the guideline, the first-line 
treatment options for uncomplicated UTIs include 
nitrofurantoin monohydrate, trimethoprim sulfame-
thoxazole, fosfomycin trometamol, and pivmecilli-
nam. It is advised that fluoroquinolones and β-lactam 
agents should be reserved for alternative treatments. 
In case of uncomplicated pyelonephritis, ciprofloxa-
cin, ceftriaxone or trimethoprim sulfamethoxazole 
should be the first choice2.
The aim of this study was to identify causative 
pathogens of uncomplicated UTIs in adult patients 
admitted to our emergency department and to pro-
vide an updated information about the antimicrobial 
resistance profile with the most frequently prescribed 
empirical antibiotics (fosfomycin-trometamol (FT), 
amoxicillin-clavulanate (AC), ciprofloxacin (CIP), 
trimethoprim-sulfamethoxazole (TMP-SMX) and 
cefpodoxime (CEF)) in the Istanbul region. 
Materials and Methods
The study was conducted prospectively in a tertiary 
inner city hospital over a period from April 15 to Sep-
tember 15, 2012, after approval of the Hospital Eth-
ics and Research Committee.  Patients over 16 years 
of age admitted to emergency department with the 
diagnosis of uncomplicated UTI were enrolled in the 
study. 
Patients with septic shock, pyelonephritis, ana-
tomical or functional anomaly in the urinary tract, 
malignancy, and immunosuppression were not in-
cluded in the study. Histories of UTIs or urinary 
catheterization in the last one month and antibiotic 
usage for any reason in the last seven days were the 
other exclusion criteria.
Midstream clean catch urine samples were cul-
tured within one hour quantitatively in 5% Sheep 
Blood Agar and Eosin Methylene Blue (EMB) plates 
(bioMerieux, France) with a standard wire loop. In-
oculated agar plates were incubated at 37 °C and read 
after 24 hours. Presence of at least 105 colony forming 
units per milliliter (CFU/mL) single bacterium colo-
nies were accepted as significant bacteriuria. Identifi-
cation of the bacteria was performed by standard con-
ventional methods. If needed, they were biochemically 
tested with API system (bioMerieux, France). API 
20E was used for oxidase-negative, gram-negative 
bacilli and API20NE was used for oxidase-positive, 
gram-negative bacilli. 
Antibiotic susceptibilities were tested with Kirby-
Bauer disc diffusion system and the results were in-
terpreted according to the methods described in the 
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Clinical and Laboratory Standards Institute (CLSI) 
documents9. Mueller Hinton Agar (bioMerieux, 
France), and discs containing 200 mcg FT, 20/10 AC, 
5 mcg CIP, 1.25/23.75 mcg TMX-SMX and 10 mcg 
CEF (Oxoid, UK) were used for testing antibiotic 
susceptibility, respectively. For the purpose of quality 
control, E. coli ATCC 25922 was used as the standard 
strain in all assays. In the study, the susceptibility 
level of the isolated microorganisms against the tested 
antibiotics was determined as ‘susceptible’, ‘interme-
diate’ or ‘resistant’ according to the susceptibility zone 
diameter9.
Statistical analysis
The SPSS 20.0 program was used on data analysis. 
In descriptive statistics, data on the frequency, rate, 
mean and standard deviation  were used. The distribu-
tion of variables was checked by Kolmogorov-Smirnov 
test. Independent-samples t test was used for quanti-
tative analysis of the data. The χ2-test was used in the 
analysis of qualitative data. Fisher test was used when 
the χ2-test conditions could not be reached.
Results
Urine culture samples of patients admitted to 
emergency medicine department with the diagnosis 
of uncomplicated UTI were evaluated. Five hundred 
urine cultures were analyzed during the study period. 
Three hundred and fifty-five (71%) samples were ob-
tained from female and the rest (29%) were obtained 
from male patients. The distribution of patients ac-
cording to age is shown in Table 1. Most of the pa-
tients were aged 21-40 (54.4%) (Table 1). 
The urine culture results were negative in 373 
(74.6%) patients. Thirty-six (7.2%) samples were con-
sidered contaminated and excluded from the study. 
Significant growth of 105 CFU/mL urine was re-
corded in 91 (18.2%) samples. Seventy-three isolates, 
representing 80.2% of the total isolates were recovered 
from female patients, while 18 (19.8%) were isolated 
from male patients (Table 2). The most common uro-
pathogen isolated from the cultures in the study group 
was E. coli (93.4%). Proteus spp. constituted 4.4% of 
the pathogens, and the rest of the isolates were Kleb-
siella spp. (2.2%) (Table 3).
Bacterial growth in urine samples from female pa-
tients was significantly higher as compared with urine 
samples of male patients (p=0.002). The mean age of 
the culture negative and culture positive patients was 
39.9±17.2 and 39.7±16.2, respectively. The age distri-
bution according to bacterial growth did not show 
statistically significant difference (p>0.05) (Table 2).
Antibiotic susceptibility studies of the isolated 
pathogens are shown in Table 4. The highest resis-
tance rate was observed to TMP-SMX (36.3%). The 
pathogens isolated from the study urine samples were 
least resistant to FT (2.2%). 
Comparison of antibiotic resistance rates between 
male and female patients revealed resistance to FT, 
CEF and CIF to be significantly higher in male pa-
tients, with the calculated p values of 0.004, 0.016 and 
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Table 2. Age and gender distribution of urine cultures
                 Urine culture
Negative                  Positive p
Gender n             % n          %
Female
Male
251      67.3
122       32.7
73       80.2
18        19.8 0.016
Age            









 33           8.8
116         31.1
  84         22.5
  47         12.6
  36           9.7
  57         15.3
   7          7.7
 27        29.7
 24        26.4
 12        13.2
   8          8.8
  13       14.3
0.980
*χ2 distribution/independent samples t-test
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0.037, respectively. Resistance rates to TMP-SMX 
and AC did not show any statistically significant gen-
der difference (Table 4). 
Resistance rates to CEF, CIP and AC were signif-
icantly higher in patients older than 50 as compared 
with those younger than 50. However, there was no 
statistically significant age difference in the resistance 
rates to FT and TMP-SMX (Table 5).
Among the female patient urine samples, 68 E. 
coli, 4 Proteus spp. and 1 Klebsiella spp. were isolated. 
Table 6 shows antibiotic resistance patterns of the 
uropathogens isolated from the samples of female pa-
tients. Of the E. coli strains cultured in female patient 
samples, 32.4% showed resistance to TMP-SMX. The 
CIP, CEF and AC resistance rates in this group were 
20.6%, 17.6% and 13.2%, respectively. E coli strains 
isolated from the samples of female patients were not 
resistant to FT (0%). 
Among the male patient urine samples, 17 E. coli 
strains and 1 Klebsiella spp. were isolated. Table 7 il-
Table 3. Distribution of isolates according to gender and age groups
Isolated pathogen 
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Table 4. Antibiotic resistance and susceptibility rates among female and male patients
              Female                              Male
        n                  %                   n                  % p
Fosfomycin
Susceptible      73 100 16 88.9
0.0004
Resistant               0 0 2 11.1
Cefpodoxime
Susceptible      60 82.2 10 55.6
0.016
Resistant               13 17.8 8 44.4
Amoxicillin/
clavulanic acid
Susceptible      63 86.3 13 72.2
0.149
Resistant               10 13.7 5 27.8
Trimethoprim/
sulfamethoxazole
Susceptible      49 67.1 9 50.0
0.176
Resistant               24 32.9 9 50.0
Ciprofloxacin
Susceptible      58 79.5 10 55.6
0.037
Resistant               15 20.5 8 44.4
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lustrates the antibiotic susceptibility studies of the 
uropathogens cultured in male patient samples. Re-
sistance rates to TMP-SMX and CIP of E. coli strains 
cultured in male patient samples were the same 
(47.1%). Resistance rates to AC and FT were 29.4% 
and 11.8%, respectively. 
The antibiotic resistance rates of the isolated patho-
gens in the culture positive patients are shown in Ta-
ble 8. Of the E. coli strains as the most common uro-
pathogens isolated in the study samples, 35.3% were 
found to be resistant to TMP-SMX. The resistance 
rates to CIP, CEF, AC and FT were 25.9%, 25.3%, 
16.5% and 2.4%, respectively. 
Discussion
Uncomplicated UTIs are generally thought of as 
UTIs occurring in otherwise healthy, young, female 
and sexually active but non-pregnant patients with-
out an underlying defect in urinary anatomy or renal 
function10. Female gender is described as a primary 
risk factor for UTIs, while some authors even accept-
ed all male UTIs as complicated2,5-7,10,11. In our study, 
women also constituted the majority of the study 
group (71.9%); furthermore, 80.2% of the culture 
positive urine samples collected for the study were 
obtained from female patients. According to our re-
Table 5. Antibiotic susceptibility and resistance rates according to age groups
<50 years 50 years<
n % n % *p
Fosfomycin
Susceptible      69 98.6 20 95.2
0.410
Resistant               1 1.4 1 4.8
Cefpodoxime
Susceptible      61 87.1 9 42.9
0.0
Resistant               9 12.9 12 57.1
Amoxicillin/
clavulanic acid
Susceptible      64 91.4 12 57.1
0.0
Resistant               6 8.6 9 42.9
Trimethoprim/
sulfamethoxazole
Susceptible      48 68.6 10 47.6
0.080
Resistant               22 31.4 11 52.4
Ciprofloxacin
Susceptible      59 84.3 9 42.9
0.0
Resistant               11 15.7 12 57.1
*χ2-test/Fisher test
Table 6. Antibiotic resistance rates of pathogens isolated from female patient samples
Pathogen growth
Female patients
E. coli Klebsiella spp. Proteus spp.
n % n % n %
Fosfomycin
Susceptible      68 100 1 100 4 100
Resistant               0 0 0 0 0 0
Cefpodoxime
Susceptible      56 82.4 0 0 4 100
Resistant               12 17.6 1 100 0 0
Amoxicillin/
clavulanic acid
Susceptible      59 86.8 0 0 4 100
Resistant               9 13.2 1 100 0 0
Trimethoprim/
sulfamethoxazole
Susceptible      46 67.6 0 0 3 75
Resistant               22 32.4 1 100 1 25
Ciprofloxacin
Susceptible      54 79.4 0 0 4 100
Resistant               14 20.6 1 100 0 0
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sults, the overall antibiotic resistance rates observed in 
male patients were higher as compared to female pa-
tients. According to the recent guidelines for optimal 
treatment of uncomplicated UTIs, it is reasonable to 
prescribe empirical antibiotics. It is also emphasized 
that routine urine culture is not usually necessary for 
uncomplicated UTIs other than pyelonephritis. How-
ever, the most important thing is that local antibiotic 
resistance pattern should be updated periodically ac-
cording to the isolated uropathogens.
We found that E. coli strains remained the pre-
dominant pathogen isolated in urine samples5-7,10. 
However, the prevalence rates vary from 75% to 95% 
worldwide, as well as in the previously conducted 
studies in Turkey12-15. In our study, the prevalence of 
E. coli strains isolated from urine samples of the study 
group was 93.4%. Although there are reports on the 
high resistance rates of uropathogens to TMP-SMX, 
it still takes place as a treatment option for UTIs. In 
many reports, the resistance rates range between 26% 
and 63%12,16-20. However, it is advised that if local re-
sistance rates exceed 20%, fluoroquinolones should 
be used instead of TMP-SMX2,5,7. In our study, the 
overall resistance to TMP-SMX was 36.3%. There-
Table 7. Antibiotic resistance rates of pathogens isolated from male patient samples
Pathogen growth
Male patients
E. coli Klebsiella spp.
n % n %
Fosfomycin
Susceptible      15 88.2 1 100
Resistant               2 11.8 0 0
Cefpodoxime
Susceptible      9 52.9 1 100
Resistant               8 47.1 0 0
Amoxicillin/
clavulanic acid
Susceptible      12 70.6 1 100
Resistant               5 29.4 0 0
Trimethoprim/
sulfamethoxazole
Susceptible      9 52.9 0 0
Resistant               8 47.1 1 100
Ciprofloxacin
Susceptible      9 52.9 1 100
Resistant               8 47.1 0 0
Table 8. Antibiotic susceptibility studies of isolated uropathogens
Pathogen growth
All patients
E. coli Klebsiella spp. Proteus spp.
n % n % n %
Fosfomycin
Susceptible      
Resistant               
83 97.6 2 100 4 100
2 2.4 0 0 0 0
Cefpodoxime
Susceptible      65 76.5 1 50 4 100
Resistant               20 23.5 1 50 0 0
Amoxicillin/
clavulanic acid
Susceptible      71 83.5 1 50 4 100
Resistant               14 16.5 1 50 0 0
Trimethoprim/
sulfamethoxazole
Susceptible      55 64.7 0 0 3 75
Resistant               30 35.3 2 100 1 25
Ciprofloxacin
Susceptible      63 74.1 1 50 4 100
Resistant               22 25.9 1 50 0 0
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fore, it seems that TMP-SMX should not be the drug 
of choice for empirical UTI treatment in our region. 
In recent years, fluoroquinolones have become 
more popular among physicians for the treatment of 
UTIs. Mollahaliloglu et al. report on the 46.4%. rate 
of fluoroquinolone prescription for the diagnosis of 
UTIs. In their study, the most frequently prescribed 
quinolone was levofloxacin (23.2%)3. Guneysel et al. 
also report that fluoroquinolones were the treatment 
of choice for UTIs. Ofloxacin was the most frequent-
ly used drug in their study17. Caterino et al. report 
that between 1996 and 2005, TMP-SMX prescrip-
tion rates decreased gradually while the frequency 
of prescription of fluoroquinolones increased21. The 
antibiotic susceptibility studies showed progressively 
increasing resistance rates for quinolones in Turkey. 
For example, Aydin et al.22 found 1.6% resistance rate 
to CIP in 1996; however, in 1999, Sencan et al.23 and 
in 2001 Sucu et al.24 reported on the resistance rates 
to CIP of 5% and 18%, respectively. The studies con-
ducted between 2000 and 2005 showed 16.8%-39% 
CIP resistance of E. coli strains isolated in UTIs14,25-27. 
According to our results, the CIP resistance rate was 
25.9% in the study group. Therefore, routine prescrip-
tion of CIP for uncomplicated UTIs cases appears to 
be questionable in all age groups. 
It seems that advanced age is also an important pa-
rameter. We found that resistance rates, especially to 
CEF, AC and CIP, were significantly higher among 
patients over 50 years compared to younger patients. 
The resistance rates of uropathogens to CEF, AC and 
CIP were 57.1%, 42.9% and 57.1%, respectively. Our 
results are consistent with literature data19,28,29. In our 
study, CEF, AC and CIP resistance rates in patients 
younger than 50 were 12.9%, 8.6% and 15.7%, re-
spectively. FT resistance was very low in both groups. 
It is reasonable to obtain urine culture routinely from 
patients over 50 years of age. According to our results, 
CEF, AC, CIP and FT can be prescribed empirically 
for patients younger than 50 years.
Because of the advantage of single-dose treatment, 
FT has recently become increasingly preferred by the 
physicians. The side effect profile is tolerable and pa-
tient compliance is generally better than with other 
drugs. Antibiotic susceptibility testing reports for 
FT are also promising worldwide. In the literature, 
resistance rates vary from 0% to 6.9%15,26,27,30-32. In 
our study, FT resistance was 2.2% in the study group 
and the resistance was higher in male patients (11%). 
The pathogens cultured in the samples of our female 
patients were all susceptible to FT. According to our 
results, FT can be preferred for uncomplicated UTIs 
in males and females of all age groups.      
Regional differences were also remarkable in the 
reports on antibiotic susceptibility testing from Tur-
key. Tasbakan et al. report on the resistance rates of 
E. coli strains of 39%, 11% and 43% to CIP, AC and 
TMP-SMX, respectively33. Ay et al. report on the re-
sistance rates of 21%, 40% and 42% to CIP, AC and 
TMP-SMX, respectively34. In the study by Bingöl et 
al., E. coli strains showed 16.8% resistance to CIP and 
35% resistance to TMP-SMX35. Our study was con-
ducted in Istanbul, and 35.3% of the E. coli strains, 
which were the most common uropathogens isolated 
from the samples, were resistant to TMP-SMX. The 
resistance rates to CIP, CEF, AC and FT were 25.9%, 
25.3%, 16.5% and 2.4%, respectively. Therefore, re-
gional differences should also be taken in consider-
ation when deciding on the choice of empirical an-
tibiotics. Local microbiology laboratories should also 
report their surveillance data periodically.
Conclusion
Resistance rates, especially to CEF, AC and CIP, 
were significantly higher in patients older than 50. 
Therefore, it is reasonable to obtain routine urine 
culture from this group of patients. In the manage-
ment of uncomplicated UTIs, TMP-SMX should be 
excluded from empirical treatment, while fosfomycin 
could be a viable option in all age groups.
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değerlendirilmesi. Ankem Derg. 2006;20(1):26-30. (in Turk-
ish)
15. Kamenski G, Wagner G, Zehetmayer S, Fink W, Spiegel W, 
Hoffmann K. Antibacterial resistances in uncomplicated uri-
nary tract infections in women: ECO.SENS II data from pri-
mary health care in Austria. BMC Infect Dis. 2012;12:222. 
doi: 10.1186/1471-2334-12-222.
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Sažetak
OTPORNOST NA TRIMETOPRIM-SULFAMETOKSAZOL I STOPE OSJETLJIVOSTI NA FOSFOMICIN 
KOD NEKOMPLICIRANIH INFEKCIJA MOKRAĆNOG SUSTAVA – JE LI VRIJEME ZA PROMJENU 
PREPORUČENIH ANTIMIKROBNIH LIJEKOVA
O. Guneysel, E. Suman i T. Cimilli Ozturk
Infekcije mokraćnog sustava (urinary tract infection, UTI) spadaju među najčešće bakterijske infekcije u odrasle popula-
cije, a učestale su u svim dobnim skupinama i u oba spola. Isto tako, UTI su najčešća indikacija za empirijsko liječenje an-
tibioticima u hitnoj službi. Cilj ovoga istraživanja bio je utvrditi stope otpornosti na antibiotike u liječenju nekomplicirane 
UTI. U ovo poprečno ispitivanje bili su uključeni odrasli bolesnici primljeni na hitni odjel s nekompliciranom UTI. Uzorci 
srednjeg mlaza mokraće uzeti su pod sterilnim uvjetima i kvantitativno kultivirani. Nakon 24 sata uzorci koji su pokazivali 
105 CFU/mL testirani su na osjetljivost na antibiotike. Otpornost na fosfomicin-trometamol (FT), amoksicilin-klavu-
lansku kiselinu (AC), ciprofloksacin (CIP), trimetoprim-sulfametoksazol (TMP-SMX) i cefpodoksim (CEF) ispitana je 
pomoću Kirby-Bauerova sustava disk difuzije. Većinu organizama izoliranih u ovom istraživanju činila je Escherichia (E.) 
coli (93,4%). Među bolesnicima pozitivnim na E. coli najčešća je bila otpornost na TMP-SMX. Vrste E. coli otkrivene u 
ovoj skupini bolesnika pokazale su najmanju otpornost na FT (2,4%). Stope antibiotske otpornosti, poglavito na CEF, AC 
i CIP, bile su značajno više u bolesnika starijih od 50 godina. Zaključuje se kako bi u liječenju nekomplicirane UTI trebalo 
iz empirijskog liječenja isključiti TMP-SMX, dok bi fosfomicin mogao biti koristan u svim dobnim skupinama. 
Ključne riječi: Urinarne infekcije – farmakoterapija; Lijekovi, rezistencija, bakterijska; Fosfomicin – terapijska primjena; 
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